Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE

New Fund Promises Low-Cost Malaria Treatment

By Pharmaceutical Processing | April 17, 2009

OSLO (AP) — A $225 million fund to provide low-price anti-malaria medicine was launched in the Norwegian capital Friday to fight a disease that kills 2,000 children a day. Malaria kills more than 880,000 people a year, at least 85 percent of them are children and most victims are in Africa, said Norway’s Foreign Minister Jonas Gahr Stoere. New drug combinations have been developed to treat strains of malaria that have become resistant to the old remedies, but they cost 10 to 40 times more and are available to only 20 percent of those with the disease, according to a statement from the new body, the Affordable Medicines Facility for Malaria. The program will cut the cost from $6 to $10 per treatment to between 20 and 50 cents by negotiating price cuts with pharmaceutical companies and through subsidies from international donors. “The age when the world had effective drugs against infectious diseases but let millions die … because they couldn’t afford them is over,” said Norway’s Foreign Minister Jonas Gahr Stoere. The program will start in 11 African countries — Benin, Cambodia, Ghana, Kenya, Madagascar, Niger, Nigeria, Rwanda, Senegal, Tanzania and Uganda — and later expanded worldwide. The Affordable Medicines Facility for Malaria was launched by Roll-Back Malaria, a public-private partnership that includes UNICEF, the World Bank, the governments of Norway, the Netherlands and Britain, the Bill and Melinda Gates Foundation, and the Clinton Foundation.

Related Articles Read More >

These are the logos of Otsuka Medical and ICU Medical.
ICU Medical, Otsuka Pharmaceutical Factory launch joint IV supply chain venture
Amgen
Amgen to spend $900M to expand U.S. biopharma manufacturing
Roche
Roche to invest $50B in U.S. over next five years
Thermo Fisher Scientific
Thermo Fisher to invest $2B on U.S. manufacturing
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE